Macrogenics (MGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,295 | -15,367 | -3,108 | -261 | 2,944 |
| Depreciation Amortization | 1,317 | 835 | 398 | 1,193 | 835 |
| Accounts receivable | -3,311 | -641 | 258 | 42 | -235 |
| Accounts payable and accrued liabilities | 1,219 | 808 | 1,964 | -570 | -1,941 |
| Other Working Capital | 3,134 | 14,875 | 7,984 | -16,592 | -17,787 |
| Other Operating Activity | 4,341 | 1,226 | -1,610 | 2,016 | 3,196 |
| Operating Cash Flow | $-12,595 | $1,736 | $5,886 | $-14,172 | $-12,988 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,914 | -1,242 | -447 | -2,961 | -2,037 |
| Investing Cash Flow | $-1,914 | $-1,242 | $-447 | $-2,961 | $-2,037 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 77,219 | 77,039 | 76,801 | 85,871 | 851 |
| Financing Cash Flow | $77,219 | $77,039 | $76,801 | $85,871 | $851 |
| Beginning Cash Position | 116,481 | 116,481 | 116,481 | 47,743 | 47,743 |
| End Cash Position | 179,191 | 194,014 | 198,721 | 116,481 | 33,569 |
| Net Cash Flow | $62,710 | $77,533 | $82,240 | $68,738 | $-14,174 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,595 | 1,736 | 5,886 | -14,172 | -12,988 |
| Capital Expenditure | -1,914 | -1,242 | -447 | -2,961 | -2,037 |
| Free Cash Flow | -14,509 | 494 | 5,439 | -17,133 | -15,025 |